1-(4-Chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea

Catalog No. :
ACRFCV243
CAS No. :
688763-64-6
Molecular Formula :
C17H17Cl2FN4O4S
Molecular Weight :
463.32

IUPAC Name:1-(4-chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea

1-(4-Chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$63.00Login to see priceInquiryInquiry
10mg98%$301.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea
IUPAC Name1-(4-chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea
MDL No.MFCD18633293
Molecular FormulaC17H17Cl2FN4O4S
Molecular Weight463.32
SMILESO=C(NC1=CC=C(Cl)C(S(=O)(N2CCNCC2)=O)=C1O)NC3=CC=CC(F)=C3Cl
InChI KeyYQYFEGTYCUQBEI-UHFFFAOYSA-N
Synonym1-(4-chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea | SB-656933
CAS No.688763-64-6
PubChem CID10479502

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRFCV243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRFCV243 route product structure diagram
    ACRFCV243688763-64-6
Inquiry

2. ACRFCV243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRFCV243 route product structure diagram
    ACRFCV243688763-64-6
Inquiry

Comments (0)